Cost Saving Potential of an Early Detection of Atrial Fibrillation in Patients after ICD Implantation

• Published in: BioMed research international 2018-01, Vol.2018 (2018), p.1-12
• Main Authors: Kolb, Christof, Lennerz, Carsten, Grebmer, Christian, Hauser, Tino, Belke, Roberto, Reinhold, Thomas, Semmler, Verena
• Format: Article
• Language: English
• Subjects: Atrial fibrillation; Atrial Fibrillation - complications; Atrial Fibrillation - diagnosis; Atrial Fibrillation - economics; Biomedical research; Cardiac arrhythmia; Cardiovascular equipment; Comparative analysis; Computer simulation; Cost engineering; Cost Savings; Costs; Defibrillators; Defibrillators, Implantable; Detection; Economic aspects; Female; Fibrillation; Health care; Health risks; Heart Atria; Heart failure; Humans; Implantation; Implants, Artificial; Incidence; Male; Markov Chains; Markov processes; Medical care, Cost of; Medical equipment and supplies industry; Medical test kit industry; Mortality; Patients; Prosthesis; Risk groups; Rivaroxaban; Stroke; Stroke (Disease); Stroke - etiology; Stroke - prevention & control
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2018/3417643

Atrial fibrillation (AF) is a relevant comorbidity in recipients of implantable cardioverter-defibrillators (ICD). Latest generation single-chamber ICD allow the additional sensing of atrial tachyarrhythmias and, therefore, contribute to the early detection and treatment of AF, potentially preventing AF-related stroke. The present study aimed to measure the impact on patient-related costs of this new ICD compared to conventional ICD. A Markov model was developed to simulate the long-term incidence of stroke in patients treated with a single-chamber ICD with or without atrial sensing capabilities. The median annual cost per patient and its difference, the number of strokes avoided, and the cost per stroke avoided were estimated. During a 9-year horizon, the costs for the ICD and stroke treatment were €570 per patient-year for an ICD with atrial sensing capabilities and €491 per patient-year for a conventional ICD. Per 1,000 patients, 4.6 strokes per year are assumed to be avoided by the new device. Higher CHA2DS2-VASc scores are associated with higher numbers of avoided strokes and larger potential for cost savings. Apart from clinical advantages, the use of ICD with atrial sensing capabilities may reduce the incidence of stroke and, in high-risk patients, may also contribute to reduce overall health care costs.